SCHEMBL3250424

SCHEMBL3250424

Nc1ccc(Oc2cccc(NC(=O)O)c2)cc1N

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A1 P22736 1/20 0.52
MITF O75030 1/20 0.51
ALDH1A1 P00352 1/20 0.51
POLB P06746 1/20 0.51
MAPK1 P28482 1/20 0.51
HTT P42858 1/20 0.51
CDK8 P49336 7/20 0.50
CA12 O43570 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
CA9 Q16790 1/20 0.50
HPSE Q9Y251 1/20 0.50
MAPT P10636 2/20 0.49
RAB9A P51151 2/20 0.49
LMNA P02545 1/20 0.49
HPGD P15428 1/20 0.49
F13A1 P00488 1/20 0.48
TGM2 P21980 1/20 0.48
MEN1 O00255 1/20 0.47
NPC1 O15118 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4366143 0.87 MTNR1A (0.57) NR4A1ALDH1A1MAPK1HTTCDK8
SCHEMBL5153495 0.86 ALDH1A1 (0.58) MITFALDH1A1POLBMAPK1HTT
SCHEMBL3244600 0.85 CDK8 (0.48) MITFALDH1A1POLBMAPK1HTT
SCHEMBL6392968 0.84 MITF (0.69) MITFALDH1A1POLBMAPK1HTT
SCHEMBL2192229 0.83 MEN1 (0.48) MITFALDH1A1POLBMAPK1HTT
SCHEMBL2192232 0.83 MEN1 (0.48) MITFALDH1A1POLBMAPK1HTT
SCHEMBL2864280 0.80 CDK8 (0.76) CDK8
SCHEMBL20995657 0.80 ALDH1A1 (0.56) MITFALDH1A1POLBMAPK1HTT
SCHEMBL5169625 0.78 FFAR1 (0.69) MITFALDH1A1POLBMAPK1HTT
SCHEMBL5169615 0.78 FFAR1 (0.69) MITFALDH1A1POLBMAPK1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2181987-B9 2-Carbonylaminobenzothiazoles and their use for the prophylaxis and treatment of cancer TAKEDA PHARMACEUTICAL (JP) 2014-09-03 EP disclosed
EP-2181987-B1 2-Carbonylaminobenzothiazoles and their use for the prophylaxis and treatment of cancer TAKEDA PHARMACEUTICAL (JP) 2014-03-05 EP disclosed
US-8324395-B2 Heterocyclic compound and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-12-04 US disclosed
EP-2181987-A1 HETEROCYCLIC COMPOUND AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2010-05-05 EP disclosed